Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2–17 years: systematic review and meta-analysis

BACKGROUND: Randomised controlled trials have evaluated the recombinant tetravalent dengue vaccine (CYD-TDV). However, individual results may have little power to identify differences among the populations studied. OBJECTIVE: To evaluate efficacy, immunogenicity and safety of CYD-TDV in the preventi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Open
Egile Nagusiak: Rosa, Bruno Rodrigues, da Cunha, Antonio José Ledo Alves, Medronho, Roberto de Andrade
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2019
Gaiak:
Evidence Based Practice
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6429993/
https://ncbi.nlm.nih.gov/pubmed/30872537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-019368
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak